blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2825205

EP2825205 - POLYMERIC CONJUGATES OF C1-INHIBITORS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  29.01.2016
Database last updated on 03.09.2024
Most recent event   Tooltip29.01.2016Application deemed to be withdrawnpublished on 02.03.2016  [2016/09]
Applicant(s)For all designated states
Belrose Pharma Inc.
500 College Road East, Suite 205
Princeton, NJ 08540 / US
[2015/04]
Inventor(s)01 / ZHAO, Hong
34 Bella Vista Court
Edison New Jersey 08820 / US
02 / YANG, Karen
48 Netherwood Circle
Edison New Jersey 08820 / US
 [2015/04]
Representative(s)V.O.
P.O. Box 87930
2508 DH Den Haag / NL
[N/P]
Former [2015/04]Jansen, Cornelis Marinus, et al
V.O.
Johan de Wittlaan 7
2517 JR Den Haag / NL
Application number, filing date13761145.515.03.2013
WO2013US32122
Priority number, dateUS201261612213P16.03.2012         Original published format: US 201261612213 P
US201361749840P07.01.2013         Original published format: US 201361749840 P
US201361749842P07.01.2013         Original published format: US 201361749842 P
US201361749848P07.01.2013         Original published format: US 201361749848 P
[2015/04]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013138730
Date:19.09.2013
Language:EN
[2013/38]
Type: A1 Application with search report 
No.:EP2825205
Date:21.01.2015
Language:EN
The application published by WIPO in one of the EPO official languages on 19.09.2013 takes the place of the publication of the European patent application.
[2015/04]
Search report(s)International search report - published on:KR19.09.2013
ClassificationIPC:A61K47/30, A61K47/42, A61K31/40, A61K47/48
[2015/04]
CPC:
A61K38/57 (EP,US); A61K38/55 (EP,US); A61K47/60 (EP,US);
A61P37/00 (EP); A61P37/02 (EP); A61P37/06 (EP);
A61P43/00 (EP); A61P7/10 (EP); C07K14/8121 (EP,US);
A61K38/00 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/04]
TitleGerman:POLYMERKONJUGATE VON C1-INHIBITOREN[2015/04]
English:POLYMERIC CONJUGATES OF C1-INHIBITORS[2015/04]
French:CONJUGUÉS POLYMÈRES D'INHIBITEURS DE LA C1-ESTÉRASE[2015/04]
Entry into regional phase16.09.2014National basic fee paid 
16.09.2014Search fee paid 
16.09.2014Designation fee(s) paid 
16.09.2014Examination fee paid 
Examination procedure16.09.2014Examination requested  [2015/04]
27.06.2015Loss of particular rights, legal effect: Claims
04.08.2015Despatch of communication of loss of particular rights: Claims {1}
01.10.2015Application deemed to be withdrawn, date of legal effect  [2016/09]
27.10.2015Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2016/09]
Fees paidPenalty fee
Additional fee for renewal fee
31.03.201503   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO9222320  (GENENTECH INC [US]);
 [Y]US5766897  (BRAXTON SCOTT M [US]);
 [Y]US5622930  (ELDERING ERIC [NL], et al);
 [A]US2010016550  (DONG ZHENG XIN [US], et al);
 [A]WO2011056799  (SANGART INC [US], et al);
 [A]US2009075873  (CRUZ ANTONIO [CA]);
 [A]US6420339  (GEGG COLIN [US], et al);
 [XP]US2012329127  (SIEKMANN JUERGEN [AT], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.